FDA Adverse Event Injury Summary report: N

ENDEAVOR RX

MDR report key: 3575805 · Received January 15, 2014

Report

Report Number
9612164-2014-00020
Event Type
Injury
Date Received
January 15, 2014
Date of Event
January 1, 2013
Report Date
December 17, 2013
Manufacturer
MEDTRONIC IRELAND
Product Code
NIQ
PMA / PMN Number
P060033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS: INHERENT RISK OF PROCEDURE ¿ (PERFORATION); PATIENT¿S CONDITION AFFECTED EFFECTIVENESS OF DEVICE (LESION MORPHOLOGY) ¿ SEVERE STENOSIS. (NO RESULTS AVAILABLE SINCE NO EVALUATION PERFORMED) - DEVICE OR PROCEDURAL IMAGES NOT PROVIDED FOR REVIEW ¿ DEVICE NOT RETURNED FOR EVALUATION; (RELATED TO OPERATIONAL CONTEXT) - EXCESSIVE PRESSURE IN THE STENT MOUNTED BALLOON (16ATM) WAS ONE OF THE REASONS FOR THE PERFORATION. CONCLUSIONS: DEVICE FAILURE/LACK OF EFFECTIVENESS RELATED TO PATIENT CONDITION (LESION MORPHOLOGY) ¿ SEVERE STENOSIS. INHERENT RISK OF PROCEDURE ¿ (PERFORATION); (RELATED TO OPERATIONAL CONTEXT) - EXCESSIVE PRESSURE IN THE STENT MOUNTED BALLOON (16ATM) WAS ONE OF THE REASONS FOR THE PERFORATION. (B)(4). OPTICAL COHERENCE TOMOGRAPHIC AND ANGIOSCOPIC ASSESSMENTS OF ARTERIAL HEALING IN CORONARY ARTERY PERFORATION AFTER IMPLANTATION OF ZOTAROLIMUS-ELUTING STENT INTERNATIONAL HEART JOURNAL INT HEART J 2013; 54: 332- ISSUE 54. DATE OF EVENT = PUBLICATION DATE (YEAR ONLY VALID).

Description of Event or Problem · 1

PHYSICIAN IMPLANTED 1 ENDEAVOR DRUG-ELUTING STENT TO A LESION IN THE LCX WITH SEVERE STENOSIS, TO A MAXIMAL PRESSURE OF 16 ATM. A PERFORATION WAS NOTED AND TREATED WITH A STENT DELIVERY BALLOON BEING INFLATED AT 8ATM¿S 3 TIMES FOR 10 MINUTES. THE PERFORATION SITE WAS SEALED. IT WAS REPORTED THAT EXCESSIVE PRESSURE IN THE STENT MOUNTED BALLOON (16ATM) WAS ONE OF THE REASONS FOR THE PERFORATION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
40269 ENDEAVOR RX STENT, CORONARY, DRUG-ELUTING NIQ MEDTRONIC IRELAND

Patients

Seq Age Sex Outcome Treatment
1 00069 YR Required Intervention CLOPIDOGREL AND ASPIRIN.